Acute Lymphoblastic Leukemia

Study Aims to Evaluate JZP-458 in ALL/Lymphoblastic Lymphoma Subgroup
June 10, 2020

A phase II/III study of JZP-458 in patients with acute lymphoblastic leukemia/lymphoblastic lymphoma who are hypersensitive to E. coli-derived asparaginases was announced at the 2020 ASCO Virtual Scientific Program.

Study May Aid AYAs in Weighing Risks, Benefits of Clinical Trial Participation
June 09, 2020

Trends in favor of better clinical outcomes were observed for those on-trial in this retrospective matched cohort study of patients with cancer who were treated on a phase III clinical trial compared with those who received standard therapy and/or were off trial.

Consuming Antioxidants Through Dietary Intake Beneficial for Patients with Childhood ALL
May 08, 2020

This study found that the consumption of antioxidants through dietary intake was correlated with reduced rates of infection or mucositis, with no increased risk of relapse or reduced survival.